Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Coronavirus Update: Regeneron's New Antibody Efficacy; Pfizer And Merck Strike US Contracts

Dec 31 2020

• By Scrip Team

Coronavirus

Related Content

Regeneron’s COVID-19 Antibody Cocktail Shows Early Promise, But Does It Merit An EUA?

Sep 30 2020

Pfizer’s US Contract Sets The Financial Bar For COVID-19 Vaccines

Jul 22 2020

Merck & Co. Buys Out OncoImmune For Phase III COVID-19 Therapy

Nov 23 2020

Regeneron COVID-19 Cocktail’s Flame To Burn Brightly But Unclear For How Long

Nov 23 2020

Pfizer Rose To The COVID-19 Challenge And The Stars Aligned

Dec 12 2020

Coronavirus Update: Moderna Snags Vaccine EUA

Dec 19 2020

Related Companies

Pfizer Inc.

BioNTech SE

Moderna, Inc.

Johnson & Johnson

Merck & Co., Inc.

Regeneron Pharmaceuticals, Inc.

Additional Topics

Coronavirus COVID-19 Deals Vaccines Companies Commercial BioPharmaceutical

More from COVID-19

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window